Scott Ledger
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2.
Journal: Drug delivery and translational research
Published: December 02, 2025
Respiratory Delivery of Highly Conserved Antiviral siRNAs Suppress SARS-CoV-2 Infection.
Journal: International journal of molecular sciences
Published: October 21, 2025
Advances in HIV Gene Therapy.
Journal: International journal of molecular sciences
Published: November 02, 2023
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.
Journal: Antiviral research
Published: April 21, 2023
Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection.
Journal: Pharmaceutics
Published: May 27, 2022
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.
Journal: International journal of molecular sciences
Published: February 03, 2022
RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
Journal: Retrovirology
Published: March 16, 2018
Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.
Journal: The journal of gene medicine
Published: December 21, 2017
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
Journal: Viruses
Published: May 01, 2015
A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.
Journal: PLoS computational biology
Published: February 24, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026